Healthy Men Clinical Trial
Official title:
Single Dose, Dose-Ranging and 28-Day Repeat-Dose Safety and Tolerability, Pharmacokinetics, and Pharmacodynamics Study of Dimethandrolone Undecanoate (DMAU) in Healthy Men
The long term objective is to develop a new male hormone Dimethandrolone Undecanoate (DMAU)
as a male hormonal contraceptive.
The study has two parts. The first is a dose escalating study in healthy to assess the safety
and tolerability of single dose oral administration of DMAUin healthy men.(Completed)
The second is to study the safety and tolerability of DMAU after 28 days of repeated daily
dosing of DMAU in healthy men. (Currently Recruiting) In both parts the investigators will
also study the pharmacokinetics of Dimethandrolone (DMA) in the serum after oral
administration of DMAU.
The study will be conducted in two centers.
28-Day Repeat-Dose, Dose-Escalation Study: Based on the safety and tolerability of the single
dose study and serum DMA levels attained, three doses of two formulations of DMAU were
selected for a dose-escalating 28-day repeat dose study. Safety will be assessed in subjects
receiving lower dosages before additional men receive higher doses for 28 days. Up to 100 men
will be randomized to receive either active drug or an identical number of capsules of
placebo. The 24-hour detailed PK of DMA will be assessed on day 1 and 28. Trough levels of
DMA will be obtained throughout the 28-day period and at 48 and 72 hours after the last dose.
In addition to safety and tolerability, suppression of serum T, gonadotropins, and SHBG will
also be assessed as secondary pharmacodynamic (PD) endpoints. Psychosexual diaries for 7
consecutive days and PHQ-9 (questionnaire)will be obtained before and at the end of the study
period.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02575209 -
Gender Differences in Social Cognition in Patients With Schizophrenia of Recent Diagnosis and Healthy Controls Subjects
|
N/A | |
| Completed |
NCT00900107 -
Time-Dependent Mobilization of Circulating Progenitor Cells During Strenuous Exercise in Healthy Individuals
|
N/A | |
| Completed |
NCT02517775 -
Effects of Cranberry Consumption in Vascular Function in Healthy Individuals
|
N/A | |
| Active, not recruiting |
NCT03298373 -
28-Day Repeat-Dose, Dose Escalation Study of 11-β Methyl Nortestosterone Dodecylcarbonate (11β-MNTDC) in Healthy Men
|
Phase 1 | |
| Completed |
NCT03339167 -
Metabolic Availability of Lysine From Millet in Adult Men
|
N/A | |
| Completed |
NCT01710280 -
Palmitic Acid in the Sn-2 Position of Triacylglycerols and Postprandial Lipemia
|
N/A | |
| Completed |
NCT01130948 -
Sleep, Breathing and Psychomotor Performance at Altitude: A Physiologic Study in Healthy Subjects
|
N/A | |
| Recruiting |
NCT05523674 -
Effects of Warm-up Intensity and Blood Flow Restriction
|
N/A | |
| Not yet recruiting |
NCT05865574 -
A Comparative Pharmacokinetic Study to Evaluate Different Manufacturing Batches of BAT1706 Injection
|
Phase 1 | |
| Completed |
NCT01293591 -
Garlic Intake And Biomarkers Of Cancer Risk
|
N/A | |
| Completed |
NCT01296997 -
Calcium Phosphate and Incretins
|
N/A | |
| Completed |
NCT00935662 -
A First Time in Man, Study to Assess the Safety of AZD8329 After Single Ascending Oral Doses
|
Phase 1 | |
| Completed |
NCT01221558 -
Effects of Lycopene on Oxidative Stress and Markers of Endothelial Function Healthy Men
|
Phase 3 | |
| Active, not recruiting |
NCT05825781 -
Study, Evaluating Pharmacokinetics, Immunogenicity and Safety Profiles of Pertuzumab Compared to Perjeta® in Healthy Man
|
Phase 1 | |
| Completed |
NCT02994602 -
Study of Serum Testosterone and Nestorone in Females After Secondary Exposure to Nestorone ® (NES) + Testosterone (T) Combined Gel Applied to Shoulders and Upper Arms in Males
|
Phase 1 | |
| Completed |
NCT02365987 -
The Acute Effects of Interesterification of Commercially Used Fats on Postprandial Lipaemia and Satiety
|
N/A | |
| Completed |
NCT02093169 -
D2 Dopamine Receptor Occupancy After Oral Dosing of Lu AF35700 in Healthy Men Using [11C]-PHNO as Tracer Compound
|
Phase 1 | |
| Completed |
NCT02072278 -
Electroencephalography Study Investigating the Effects of Vortioxetine in Healthy Male Subjects
|
Phase 1 | |
| Completed |
NCT03411005 -
Metabolic Availability of Lysine From Sorghum in Adult Men
|
N/A | |
| Recruiting |
NCT02927210 -
Injectable DMAU for Male Contraception in Healthy Male Volunteers (CCN015)
|
Phase 1 |